Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

UnitedHealthcare UHC UnitedHealth

Change Healthcare may sell off assets to close UnitedHealth deal, plus more vendor news

Also, Agfa to raise prices for its radiology solutions, Philips sees comparable sales decline, and Qure.ai scores an FDA clearance.

Thumbnail

Mark Cuban’s prescription drug company launches online pharmacy for affordable medications

The Mark Cuban Cost Plus Drug Company promises to bypass middlemen and "outrageous" markups for more than 100 medications.

Thumbnail

Only 21% of U.S. hospitals comply with price transparency mandate for shoppable imaging exams

The maximum charge for a contrast-enhanced pelvic CT was listed as $14,238 compared to a minimum of $193, exemplifying a wide variation in exam pricing.

Salt Lake City Utah

Private equity-backed Rayus Radiology reveals additional expansion plans

The growing imaging group is launching two new outpatient centers, ballooning its national total to 152 and counting. 

Thumbnail

Insurers spent millions on ivermectin prescriptions for COVID-19, despite the drug being ineffective

Private and Medicare insurers spent nearly $2.5 million on the anti-parasite drug during a single week in August 2021, researchers reported in JAMA Network Open.

Medicare money payment physician

Diagnostic radiology absorbed a 44% Medicare reimbursement reduction over the last decade

The numbers appear “troublesome” and offer strong evidence of the need for reform, experts wrote in Current Problems in Diagnostic Radiology. 

Thumbnail

Radiology practice sells its offices in $29M leaseback deal, netting 77% profit

Windsong Radiology unloaded its two connected buildings to a Nashville, Tennessee, REIT after acquiring them for $16.25M in 2014

Thumbnail

Philips sees sales fall $400M below expectations amid global supply chain pressures

However, Q4 bright spots included “robust” order intake with 4% growth, driven by gains in its Diagnosis & Treatment business, leaders said Wednesday.